Navigation Links
Can hormone help treat multiple sclerosis long-term?
Date:3/10/2013

SAN DIEGO A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

The study involved 23 people with MS who were taking beta-interferon treatment and had at least one relapse or brain scan showing new disease activity within the previous year. They were considered to have "breakthrough" MS, which means that their treatment that had been working previously stopped being effective, leading to worsening disability and more frequent relapses, as well as increased evidence of disease activity on brain scans.

The study participants were given either ACTH or methylprednisolone as pulse therapy monthly in addition to their regular treatment for one year. The people with MS knew which treatment they were receiving, but the researchers examining them did not.

The participants were tested every three months for 15 months. Over that time, those receiving ACTH had fewer relapses, or 0.08 cumulative relapses per patient compared to 0.8 relapses per patient for those receiving methylprednisolone. Those taking ACTH also had no cases of psychiatric side effects, while those taking methylprednisolone had a cumulative number of 0.55 psychiatric episodes per patient.

"These results are of interest because few treatments are available for people with breakthrough MS," said study author Regina Berkovich, MD, PhD, of Keck Medical Center of USC in Los Angeles. "Further studies, including randomized controlled trials, are needed to validate these preliminary findings, but the results suggest a potential benefit of ACTH pulse therapy in breakthrough MS."

While ACTH has been approved for use in MS relapses for many years, its cost has limited its use to only those patients who are in need of a relapse treatment alternative to corticosteroids. This is believed to be the first study to have been done on its use as a chronic treatment for MS. ACTH is not FDA-approved for use as chronic treatment for MS.


'/>"/>

Contact: Rachel Seroka
rseroka@aan.com
612-928-6129
American Academy of Neurology
Source:Eurekalert

Related medicine news :

1. Procedure Lowers Hunger Hormone to Help Obese Lose Weight
2. Stress hormone foreshadows postpartum depression in new mothers
3. Thyroid hormones reduce damage and improve heart function after myocardial infarction in rats
4. Renew Health and Wellness, a Hormone Replacement and Weight Loss Clinic Based in St. Louis, MO, Announces the Addition of Tara Smith, NP, to Their Staff of Professionals
5. Could Duration of Prostate Cancer Hormone Therapy Be Halved?
6. Anti-Muellerian hormone predicts IVF success
7. Study finds hormones can change the breasts genetic material
8. Test for hormone-disrupting chemicals gets global seal of approval
9. Love Hormone May Aid Womens Recovery After Childbirth
10. New hormone therapy shows promise for menopausal symptoms in animal model
11. Hormone Replacement Clinic, Renew Health and Wellness Opens in Richmond, Virginia. New Center Specializes in Anti-Aging Therapies for both Women and Men.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... “The Road To Restoration”: an informative and enlightening book for ... week showing of hands. “The Road To Restoration” is the creation of published author, ... the brass ring that you could reach out for, and grab, on the old ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Business ... Summit in Reston, VA on March 21-22, 2017. This premier event features business ... experiences from a cross-section of industries such as financial services, insurance, healthcare, manufacturing, ...
(Date:12/6/2016)... ... December 06, 2016 , ... The International Vaccine ... a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will ... Korea for emergency deployment in the event of a future outbreak. , IVI ...
(Date:12/6/2016)... ... December 06, 2016 , ... i2i Population Health, a ... a vice president of sales. , “Ajdin understands that building a successful sales ... understand what each client needs, and is persistent in building towards a solution ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... N.Y. , Dec. 6, 2016 ... a reason to be hopeful.  A special kind of ... a less anxious life. Photo - ... Robert Buck, the psychotherapist who developed and ... breakthrough approach to overcoming anxiety and worry.  "Anxiety ...
(Date:12/5/2016)... , Dec. 5, 2016  Zimmer Biomet Holdings, ... announced that, pursuant to its previously-announced cash tender ... in the table below (collectively, the "Notes"), approximately ... validly tendered and not validly withdrawn on or ... time, today, December 5, 2016 (the ...
(Date:12/5/2016)... France Glaucoma Surgery Devices Market Outlook to 2022 ... Market Outlook to 2022", provides key market data on ... value, in millions of US dollars, volume (in units) ... Micro Catheters and Glaucoma Drainage Devices. The report ... each of these market segements, and global corporate-level profiles ...
Breaking Medicine Technology: